Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity & Safety of Bio Farma's MR Vaccine in Indonesian Infants
NCT04183114Phase 3Completed
- Sponsor
- Bio Farma
- Start
- Sep 2019
- Primary completion
- Nov 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Measles and Rubella Vaccine (PT Bio Farma) in measles, rubella, sponsored by Bio Farma. Started Sep 2019; status: completed.
02
Drugs
Measles and Rubella Vaccine (PT Bio Farma)
03
Conditions
measlesrubella
Beyond the preview
Go deeper on NCT04183114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04183114.